Rewalk Robotics

ReWalk Robotics, the Marlborough manufacturer of robotic medical devices for people with lower limb disabilities, received the first European clearance of a suit for stroke rehabilitation. 

Marlborough medical equipment manufacturer ReWalk Robotics narrowed its first-quarter losses as it keys in on releasing more products in Europe and the U.S.

ReWalk Robotics shares are up more than 5% Thursday after the company announced an increasing amount of Blue Cross Blue Shield beneficiaries winning requests for coverage.

ReWalk Robotics saw its stock skyrocket Tuesday as the company said it has sold its first personal exoskeleton device to a spinal cord injury patient via insurance firm Cigna Corp.

ReWalk Robotics is hoping to raise $4.25 million from institutional investors by offering more than 816,000 shares in a registered direct offering.

ReWalk Robotics is eyeing profitability in the near future with new products set to come online in different markets.

ReWalk Robotics has submitted a 510k filing to the U.S. Food & Drug Administration for its ReStore exoskeleton suit.

Marlborough medical device firm ReWalk Robotics said a major health insurer will take requests for coverage of exoskeleton medical devices for people with spinal cord injuries on a case-by-case basis.

Marlborough medical device manufacturer ReWalk Robotics is expecting 2018 revenues to come in down about 16 percent from last year.

The 500th medical device for patients with spinal cord injuries has been placed by Marlborough manufacturer ReWalk Robotics.